Charles Schwab Investment Management Inc Hille Vax, Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Hille Vax, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 75,596 shares of HLVX stock, worth $140,608. This represents 0.0% of its overall portfolio holdings.
Number of Shares
75,596
Previous 75,596
-0.0%
Holding current value
$140,608
Previous $133,000
15.79%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding HLVX
# of Institutions
75Shares Held
36.4MCall Options Held
0Put Options Held
0-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.6MShares$19.7 Million1.01% of portfolio
-
Tang Capital Management LLC San Diego, CA4.92MShares$9.15 Million0.75% of portfolio
-
Black Rock Inc. New York, NY2.09MShares$3.89 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA1.96MShares$3.64 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.88MShares$3.5 Million0.1% of portfolio
About HilleVax, Inc.
- Ticker HLVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,427,200
- Market Cap $62.2M
- Description
- HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.